# Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer

> **NCT01446458** · PHASE1 · COMPLETED · sponsor: **Emory University** · enrollment: 13 (actual)

## Conditions studied

- Cancer of Pancreas
- Cancer of the Pancreas
- Neoplasms, Pancreatic
- Pancreas Cancer
- Pancreas Neoplasms

## Interventions

- **DRUG:** Modified FOLFIRINOX
- **RADIATION:** Stereotactic Body Radiotherapy (SBRT)

## Key facts

- **NCT ID:** NCT01446458
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2016-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01446458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01446458, "Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01446458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*